For example, the knockout of class I HDACs 1 and 3 manifests in early embryonic lethality in mice and depletion of HDAC2 results in lethal cardiac hypertrophy.30, 31, 32 Simultaneous inhibition of the activity of these HDACs yields a high potential for toxicities that result in dose-limiting side effects, restricting the full anticancer potential of HDAC inhibitors. Here, HDAC2 is linked to cardiac hypertrophy.